These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28734872)

  • 21. Exponential size distribution of von Willebrand factor.
    Lippok S; Obser T; Müller JP; Stierle VK; Benoit M; Budde U; Schneppenheim R; Rädler JO
    Biophys J; 2013 Sep; 105(5):1208-16. PubMed ID: 24010664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coarse-Grain Modeling of Shear-Induced Binding between von Willebrand Factor and Collagen.
    Wei W; Dong C; Morabito M; Cheng X; Zhang XF; Webb EB; Oztekin A
    Biophys J; 2018 Apr; 114(8):1816-1829. PubMed ID: 29694861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H.
    Hayakawa M; Kato S; Matsui T; Sakai K; Fujimura Y; Matsumoto M
    J Thromb Haemost; 2019 Jun; 17(6):975-983. PubMed ID: 30929293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers.
    O'Brien LA; Sutherland JJ; Hegadorn C; Benford K; Racz H; Rapson D; Hough C; Lillicrap D
    J Thromb Haemost; 2004 Jul; 2(7):1135-42. PubMed ID: 15219197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1-A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro.
    Brophy TM; Ward SE; McGimsey TR; Schneppenheim S; Drakeford C; O'Sullivan JM; Chion A; Budde U; O'Donnell JS
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):845-855. PubMed ID: 28279966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.
    Rauch A; Legendre P; Christophe OD; Goudemand J; van Belle E; Vincentelli A; Denis CV; Susen S; Lenting PJ
    Thromb Haemost; 2014 Nov; 112(5):1014-23. PubMed ID: 25030452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shear-Dependent Interactions of von Willebrand Factor with Factor VIII and Protease ADAMTS 13 Demonstrated at a Single Molecule Level by Atomic Force Microscopy.
    Bonazza K; Rottensteiner H; Schrenk G; Frank J; Allmaier G; Turecek PL; Scheiflinger F; Friedbacher G
    Anal Chem; 2015 Oct; 87(20):10299-305. PubMed ID: 26369694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis.
    De Ceunynck K; Rocha S; Feys HB; De Meyer SF; Uji-i H; Deckmyn H; Hofkens J; Vanhoorelbeke K
    J Biol Chem; 2011 Oct; 286(42):36361-7. PubMed ID: 21896483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices.
    Zhou Y; Qin S; Hilton T; Tang L; Cruz M; Hernandez R; Moake JL; Tian Q; Frazier OH; Dong JF; Nascimbene A
    ASAIO J; 2017; 63(6):849-853. PubMed ID: 28682993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
    Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.
    Tsai HM
    Blood; 1996 May; 87(10):4235-44. PubMed ID: 8639782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS-13.
    Nowak AA; McKinnon TA; Hughes JM; Chion AC; Laffan MA
    J Thromb Haemost; 2014 Jan; 12(1):54-61. PubMed ID: 24406064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Backbone resonance assignments of the A2 domain of mouse von Willebrand factor.
    Morimoto D; Osugi M; Mahana Y; Walinda E; Shirakawa M; Sugase K
    Biomol NMR Assign; 2021 Oct; 15(2):427-431. PubMed ID: 34286417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology.
    Okhota S; Melnikov I; Avtaeva Y; Kozlov S; Gabbasov Z
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region.
    Fu X; Chen J; Gallagher R; Zheng Y; Chung DW; López JA
    Blood; 2011 Nov; 118(19):5283-91. PubMed ID: 21917758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Domain-specific mechanical modulation of VWF-ADAMTS13 interaction.
    Li Z; Lin J; Sulchek T; Cruz MA; Wu J; Dong JF; Zhu C
    Mol Biol Cell; 2019 Jul; 30(16):1920-1929. PubMed ID: 31067148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.
    Cao W; Krishnaswamy S; Camire RM; Lenting PJ; Zheng XL
    Proc Natl Acad Sci U S A; 2008 May; 105(21):7416-21. PubMed ID: 18492805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The various states of von Willebrand factor and their function in physiology and pathophysiology.
    Huck V; Schneider MF; Gorzelanny C; Schneider SW
    Thromb Haemost; 2014 Apr; 111(4):598-609. PubMed ID: 24573248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor.
    Rottensteiner H; Seyfried BK; Kaufmann S; Fiedler C; Dong JF; Zheng XL; Plaimauer B; Scheiflinger F
    J Thromb Haemost; 2019 Dec; 17(12):2099-2109. PubMed ID: 31393047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.